Phase II study of first-line (131)I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic (18)F-fluorodeoxyglucose positron emission tomography.
about
Phase II study of first-line (131)I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic (18)F-fluorodeoxyglucose positron emission tomography.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Phase II study of first-line ( ...... positron emission tomography.
@en
Phase II study of first-line
@nl
type
label
Phase II study of first-line ( ...... positron emission tomography.
@en
Phase II study of first-line
@nl
prefLabel
Phase II study of first-line ( ...... positron emission tomography.
@en
Phase II study of first-line
@nl
P2093
P2860
P1433
P1476
Phase II study of first-line ( ...... positron emission tomography.
@en
P2093
Andrew D McQuillan
J Harvey Turner
William B G Macdonald
P2860
P304
P356
10.3109/10428194.2014.949260
P577
2014-08-19T00:00:00Z